Stephens M A, Self T H, Lancaster D, Nash T
Department of Pharmacy, Regional Medical Center, Memphis, TN 38103.
South Med J. 1989 Dec;82(12):1585-6.
Although our observation is not the first case of reduced PT response to oral anticoagulants associated with hypothyroidism, it is the only such interaction reported since 1963, and the first case involving warfarin therapy in a human being. We submit this case as a reminder of a potentially forgotten interaction, and to stress the importance of close monitoring in patients receiving warfarin therapy who have concomitant changes in thyroid function.
尽管我们的观察并非首例与甲状腺功能减退相关的口服抗凝剂PT反应降低的病例,但却是自1963年以来报告的唯一此类相互作用的病例,也是首例涉及人类华法林治疗的病例。我们提交此病例,以提醒人们注意这一可能被遗忘的相互作用,并强调在接受华法林治疗且甲状腺功能同时发生变化的患者中进行密切监测的重要性。